Expressed PD-L1 on cancer cells can bind to PD-1 receptors on the surface of tumor-infiltrating T-lymphocytes, preventing T-cell activation and eventually leading to tumor immune escape (Tumeh et al., 2014). Here, CD274 is linked to cancer.